HIF1A and intervertebral disk degenerative disorder: Notably, inhibition of Hif1α signaling activity using either a selective Hif1α inhibitor (2ME2) or conditional deletion of Hif1α in Vhl-deficient mice with DDD alleviated the pathological changes of disc degeneration.